These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 27019462

  • 1. Clinical Features and Management of Congenital Fibrinogen Deficiencies.
    Casini A, de Moerloose P, Neerman-Arbez M.
    Semin Thromb Hemost; 2016 Jun; 42(4):366-74. PubMed ID: 27019462
    [Abstract] [Full Text] [Related]

  • 2. Congenital fibrinogen disorders: an update.
    de Moerloose P, Casini A, Neerman-Arbez M.
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [Abstract] [Full Text] [Related]

  • 3. Can the phenotype of inherited fibrinogen disorders be predicted?
    Casini A, de Moerloose P.
    Haemophilia; 2016 Sep; 22(5):667-75. PubMed ID: 27293018
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and treatment of congenital fibrinogen deficiency.
    Peyvandi F.
    Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
    Casini A, Abdul Kadir R, Abdelwahab M, Manco-Johnson MJ, Raut S, Ross C, de Moerloose P, Santoro C, Acharya S.
    J Thromb Haemost; 2024 May; 22(5):1516-1521. PubMed ID: 38266678
    [Abstract] [Full Text] [Related]

  • 7. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E, Klukowska A, Zdziarska J, Zawilska K, Treliński J, Iwaniec T, Mital A, Pietrys D, Sydor W, Neerman-Arbez M, Undas A.
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [Abstract] [Full Text] [Related]

  • 8. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M, de Moerloose P, Casini A.
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [Abstract] [Full Text] [Related]

  • 9. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P.
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [Abstract] [Full Text] [Related]

  • 10. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, de Moerloose P.
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [Abstract] [Full Text] [Related]

  • 11. How I treat dysfibrinogenemia.
    Casini A, de Moerloose P.
    Blood; 2021 Nov 25; 138(21):2021-2030. PubMed ID: 33895794
    [Abstract] [Full Text] [Related]

  • 12. Rare inherited disorders of fibrinogen.
    Acharya SS, Dimichele DM.
    Haemophilia; 2008 Nov 25; 14(6):1151-8. PubMed ID: 19141154
    [Abstract] [Full Text] [Related]

  • 13. Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.
    Zhang Y, Zuo X, Teng Y.
    Clin Appl Thromb Hemost; 2020 Nov 25; 26():1076029620912819. PubMed ID: 32233805
    [Abstract] [Full Text] [Related]

  • 14. Congenital fibrinogen disorders.
    de Moerloose P, Neerman-Arbez M.
    Semin Thromb Hemost; 2009 Jun 25; 35(4):356-66. PubMed ID: 19598064
    [Abstract] [Full Text] [Related]

  • 15. Congenital fibrinogen disorders with repeated thrombosis.
    Zhang X, Zhang C, Wang B, Chen N, Sun G, Guo X.
    J Thromb Thrombolysis; 2020 Feb 25; 49(2):312-315. PubMed ID: 31542854
    [Abstract] [Full Text] [Related]

  • 16. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
    Mohsenian S, Palla R, Menegatti M, Cairo A, Lecchi A, Casini A, Neerman-Arbez M, Asselta R, Scardo S, Siboni SM, Blatny J, Zapletal O, Schved JF, Giansily-Blaizot M, Halimeh S, Daoud MA, Platokouki H, Pergantou H, Schutgens REG, Van Haaften-Spoor M, Brons P, Laros-van Gorkom B, Van Pinxten E, Borhany M, Fatima N, Mikovic D, Saracevic M, Özdemir GN, Ay Y, Makris M, Lockley C, Mumford A, Harvey A, Austin S, Shapiro A, Williamson A, McGuinn C, Goldberg I, De Moerloose P, Peyvandi F.
    Blood Adv; 2024 Mar 26; 8(6):1392-1404. PubMed ID: 38286442
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management.
    Casini A, Neerman-Arbez M, de Moerloose P.
    Blood Rev; 2021 Jul 26; 48():100793. PubMed ID: 33419567
    [Abstract] [Full Text] [Related]

  • 18. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G, Giacomelli SH, Biasoli C, Contino L, Radossi P.
    Eur J Haematol; 2019 Oct 26; 103(4):379-384. PubMed ID: 31314131
    [Abstract] [Full Text] [Related]

  • 19. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y, Kallel C, Becheur M, Dabboubi R, Elloumi M, Belaaj H, Kammoun S, Messaoud T, de Moerloose P, Toumi Nel H.
    Clin Chim Acta; 2016 Sep 01; 460():55-62. PubMed ID: 27343352
    [Abstract] [Full Text] [Related]

  • 20. Management of dysfibrinogenemia in pregnancy: A case report.
    Yan J, Deng D, Cheng P, Liao L, Luo M, Lin F.
    J Clin Lab Anal; 2018 Mar 01; 32(3):. PubMed ID: 28948631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.